David W. Higgins backs NCPE picking Wegovy over Mounjaro on cost grounds
Ireland's drug pricing body recommended semaglutide over tirzepatide for cost reasons, and Higgins says it's the right call, with a pun he didn't get to use.
Recap by typeshit. Post by David W. Higgins on X.